Constitutive genes are detected in cells in basal conditions. Stimuli such as reactive oxygen species (ROS) may up-regulate the expression of these genes, but the mechanisms involved in their continuous basal expression are unknown. As ROS concentrations are tightly maintained at intracellular level, we hypothesize that basal levels of ROS could be responsible for the expression of These findings suggest a novel role for the steady-state basal intracellular ROS concentration, which could be essential for the basal expression of constitutive AP1-dependent genes, as TGF-β1.
Introduction
Genes are considered as constitutive when they are transcribed at relatively constant levels in cells under basal conditions. Unlike inducible genes, that are transcribed only when they are needed as a consequence of specific stimuli, constitutive genes are expressed continuously in cells, and it seems that they play significant roles in the maintenance of basic cell processes. Although the transcription level of constitutive genes seems to be rather constant, it has been reported that they can be also regulated by different stimuli, such as reactive oxygen species (ROS) (7, 12, 18, 27, 43 ).
ROS consist of a variety of oxygen-derived small molecules with diverse structures. Some of these species, such as superoxide and hydroxyl radicals, are extremely unstable, whereas others like hydrogen peroxide (H 2 O 2 ) are relatively long-lived and freely diffusible (7) . They are generated in cells as a consequence of their basal function, as they are synthesized by a wide variety of enzymatic systems such as NAD(P)H oxidase, xanthine oxidase and arachidonic acid metabolizing enzymes as well as by the mitochondrial respiratory chain (7, 26, 38, 41) . Degradation of these ROS is also regulated by antioxidant enzymes, including superoxide dismutase, catalase (CAT) and glutathione peroxidase, among others. The balance between production and elimination is tightly regulated and ensures the proper maintenance of cellular metabolism and homeostasis. In general, moderate levels of ROS are involved in biological processes such as cell proliferation, differentiation and survival (11, 37) . Exogenous stimuli may also modulate ROS balance and in these cases transient ROS production can act as an intracellular signalling mechanism, regulating a broad variety of genes and cell functions (2, 31, 39) . Among ROS, H 2 O 2 is best studied as a second messenger. It mainly acts in the cells by modifying critical residues of proteins thereby regulating their catalytic activities or other functions (7, 40) .
TGF-β1 is a member of a large family of growth and differentiation factors that are involved in cell division, differentiation, migration, adhesion, death, extracellular matrix production, tissue homeostasis and embryogenesis (20, 28, 33) . It express constitutively in a wide variety of cell types.
TGF-β1 has a crucial role in tissue homeostasis and the disruption of the TGF-β1 pathway has been implicated in many human diseases, including cancer, autoimmune, fibrotic and cardiovascular diseases (20, 29) . Previous reports have showed that ROS can regulate TGF-β1 synthesis GONZÁLEZ-RAMOS ET AL. 4 (5, 12, 17, 23, 25, 32) also through the activation of the transcription factor AP-1 (12) . Taking into account this fact, we hypothesized that basal concentrations of ROS could be involved in the constitutive expression of TGF-β1.
Present experiments were devoted to analyze this hypothesis. Additional, the possible mechanisms involved in the observed effects were studied. Finally, the possibility of the different sources of ROS could play different roles in the regulation of the constitutive expression of TGF-β1 was also tested.
Results

CAT-dependent reduction of intracellular H 2 O 2 decrease TGF-β1 protein content in human mesangial cells (HMC).
In order to reduce the basal levels of H 2 O 2 , HMC were incubated for 16 h with various CAT concentrations. As previously reported (24, 34) , the intracellular CAT activity significantly increased (Fig. 1A) and a dose-dependent reduction of intracellular ROS concentration, measured by flow cytometry with fluorescent dye DCFHDA, was observed (Fig. 1B) (Fig. 1C) .
In these conditions of CAT-dependent reduction of intracellular H 2 O 2 , TGF-β1 protein synthesis was evaluated by three means. Figure 2A shows a dose-dependent reduction of TGF-β1 protein evaluated by immunoblot. When TGF-β1 content was analyzed in intact cells by immunofluorescence, CAT also reduced this protein (Fig. 2B) . Finally, total immunoreactive TGF-β1, measured by ELISA, decreased in the supernatants of HMC incubated with CAT (Fig. 2C) . Phorbol 12-myristate13-acetate (PMA), a potent stimulus for TGF-β1 synthesis (9) was used as positive control (Fig. 2 ,B-C).
Mechanisms involved in the CAT-dependent reduction of TGF-β1 protein content in human mesangial cells (HMC).
As we previously demonstrated that H 2 O 2 augmented TGF-β1 protein synthesis by increasing the steady-state levels of its mRNA (12), we first analyzed mRNA expression by quantitative-RT-PCR after catalase addition to HMC. We could observe a significant decrease of mRNA expression GONZÁLEZ-RAMOS ET AL.
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( Fig. 3A) . This reduction seemed to be due to the CAT-dependent reduction of the TGF-β1 promoter activity, evaluated by measuring of luciferase activity in cells transfected with constructions in which luciferase was under the control of the TGF-β1 promoter (Fig. 3B ). Since this promoter contains at least two AP-1 binding sequences (15) and it is also regulated by ROS (21, 30, 38) , we analyzed the activity of TGF-ß1 promoter after deletion of different response sites, in order to test the implication of AP-1 on the decreased TGF-β1 promoter activity under CAT treatment. As shown in Figure 3C , CAT inhibited the activity of the complete promoter, as well as the construction containing AP-1 site (phTG5), but did not modify activity in cells transfected with the plasmid phTG6, that did not contain the consensus sequence for AP-1.
In order to ensure the implication of AP-1 in TGF-β1 down-regulation induced by CAT, we analyzed CAT ability to modulate the basal activity of this transcription factor. For this purpose, EMSA assays were performed in HMC incubated with different CAT concentrations. As shown in Figure 3D , a significant dose-dependent reduction of the interaction between AP-1 specific oligonucleotide and nuclear proteins occurred after CAT addition. This finding was confirmed by studying the activity of the 3TP-Lux plasmid, a construction in which luciferase activity is under the control of three AP-1 sites, in HMC treated with CAT. Again, CAT induced a dose-dependent decrease of the activity of this plasmid (Fig. 3E ).
Considering together these results, it appears that basal intracellular concentration of ROS regulates the activity of AP-1 transcription factor, with the subsequent activation of genes under the control by this factor, particularly TGF-β1. To ascertain this hypothesis, the ability of CAT to modulate other proteins with different regulatory elements in their promoters was tested. The results are collected in Figure 4 . Catalase-dose-dependent decrease in eNOS protein content was observed in endothelial cells (Fig. 4A) , whereas no changes in cyclooxygense-1 (Fig. 4B ) and protein kinase Gα1 (Fig. 4C ) protein content were detected in HMC.
Importance of the different systems that synthesizes ROS in the basal TGF-β1 expression in HMC
To study the influence of different sources of ROS in the maintenance of the TGF-β1 levels, cells were incubated with pharmacological inhibitors of NADPH oxidase (diphenyleneiodonium, DPI, 10µM), mitochondrial electron-transport chain complex I (rotenone, ROT, 10µM), and xanthine oxidase (allopurinol, ALLO, 100 µM). The results were compared with those from 320 U/mL CAT. After treatments, ROS and H 2 O 2 concentration was evaluated by flow cytometry in cells loaded with DCFHDA and by confocal microscopy in cells transfected with HyPer. A relevant and similar suppression of basal ROS and H 2 O 2 synthesis was observed in all cases and the inhibition was comparable to that of CAT ( Fig. 5A-B ). In these conditions of reduced H 2 O 2 intracellular levels, only DPI and ROT inhibited TGF-β1 and 3TP-Lux promoter activity (Fig. 5C ), as well as TGF-β1 content in cell supernatants (Fig. 5D ). However, ALLO did not modify any of these parameters ( Fig. 5C-D ).
As these experiments were performed with pharmacological inhibitors, we tried to confirm some results by using genetically modified cells. Human fibroblasts mutated in mitochondrial DNA (G7896A) (3) were used to analyse the ability of a defect in the respiratory chain to modulate the basal TGF-β1 cellular expression. In these cells, a decreased concentration of the cytokine in cell extracts ( Fig. 6A ) and in supernatants ( 
Discussion
The ability of increased ROS to modulate different aspects of cell function has been widely recognized (11, 26, 37, 38, 40) . Our group has contributed to the knowledge of this regulation by demonstrating that H 2 O 2 induces mesangial cell contraction (6), stimulates cell proliferation (8) To decreased intracellular ROS concentration, CAT was added to the extracellular media of the cells. Extracellular CAT decreases H 2 O 2 in cell supernatants, with the subsequent transfer of this ROS from the intra to the extracellular media, but also penetrates into the cells (24, 34) . Our experiments confirm that intracellular CAT activity increased about three-fold after addition of 320 U/ml CAT to the cell supernatants for 16 h. Moreover, they confirmed that intracellular ROS concentration decreased about 40% with this same CAT concentration, measured by fluorescence of DCFHDA. Although this dye has been proposed as specific for H 2 O 2 , it seems that it may be also activated by other ROS (4). Thus, to be sure about changes in H 2 O 2 elicited by extracellular CAT, we transfected the cells with the HyPer plasmid (1) , that specifically responds to changes in H 2 O 2 concentrations and we confirmed the significant decrease of intracellular H 2 O 2 by CAT addition. Cells with low intracellular H 2 O 2 concentration did not show any significant toxicity, at least in the intervals that these studies were performed. However, the intracellular concentration of TGF-β1, the release of this cytokine to cell supernatants, the steady-state levels of its mRNA and its promoter activity significantly decreased in the cells. The quantitative changes observed in these parameters were comparable to the reduction in H 2 O 2 concentration. Thus, the presence of 320U/ml 9 CAT in the extracellular media decreased about 50% of TGF-β1 protein content evaluated by immunoblot and TGF-β1 mRNA quantified by RT-PCR.
Present experiments suggest that the decreased TGF-β1 promoter activity, consequence of the decreased H 2 O 2 intracellular concentration, is the basic mechanism that leads to the TGF-β1 downregulation. Since this promoter is under the control of different transcription factors (16), we tried to perform a general approach of these factors by analyzing the transcriptional activity of continuous deletions of the promoter. The complete deletion of the region between -1362 and -453 did not modify the promoter response to CAT addition, but when the deleted region included the fragment between -453 and -323 the CAT inhibition disappeared. In this region is located the specific DNA sequence that binds AP-1 thus supporting the relevance of this transcription factor in the genesis of the observed effects. In fact, the binding of AP-1 to cellular extracts progressively decreases in cells incubated with increasing concentrations of CAT, as well as the activity of 3TP-Lux construction, which specifically activates in response to AP-1. This was a rather expected result, as this factor seems to be one of the most relevant transcription factors involved in TGF-β1 regulation (16, 30) , and it is up-regulated by ROS over-production (14, 21, 30, 38) .
These experiments support the role of the basal AP-1 activity on the basal expression of TGF-β1, under the control of intracellular steady-state levels of H 2 O 2 . If AP-1 were so critical in the regulation of this process, genes under its control would have behaviours similar to TGF-β1, and the lack of response elements to AP-1 in the promoter region would determine lack of response to CAT treatment. For this purpose we analysed other proteins. The cellular content of eNOS decreased when endothelial cells were incubated with CAT, whereas no changes were observed in COX1 and PKG-α1 content in HMC after treatment with CAT. From these three proteins, only eNOS contains AP1-site in their promoter region (22, 35, 42) .
ROS are derived from several compartments inside the cells: mitochondria, peroxisomes, plasma membrane, endoplasmic reticulum, Golgi complex, lysosomes and the nucleus, where there are enzyme systems that synthesize ROS (7, 26, 37) . Although this synthesis is usually considered as a whole, probably the different enzymes are responsible for ROS production for specific cellular functions. Regarding the basal activity of AP-1 we tested the possibility that it could depend on the 
Innovation
This is the first time that a role for intracellular ROS steady-state levels in the basal expression of constitutive genes is proposed. Our findings suggest that basal levels of intracellular ROS regulate the activity of the transcription factor AP-1, and subsequently of the genes under its control, particularly TGF-ß1 in HMC and eNOS in endothelial cells. Moreover, our data suggest that the source of ROS may be relevant in this regulation. Interestingly, ATP synthesis by mitochondria seems to be one of the sources involved, suggesting a link between constitutive gene expression and cell respiration. 
Materials and Methods
Materials
Cell culture and treatment
Human mesangial cells (HMC) were prepared as described in (12, 10) . The experiments were performed in cells on passages 3-7. Human endothelial cells, EAHY926 were from American Type Culture Collection (Rockville, MD). Human fibroblasts from skin were provided by Dr Garesse. They have a mutation G7896A in the subunit II of cytochrome c oxidase (3). Fibroblasts from healthy individuals were used as control.
Cells were maintained in culture medium supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin and 10% FBS. In the case of human fibroblasts, 50µg/ml uridine was also added.
Cells were serum-deprived for 24 h and then they were incubated for 16 h with catalase (160 U/ml-640 U/ml) prepared as recommended by 36. In some experiments HMC were incubated for 16 h with diphenyleneiodonium (DPI, 10µM), rotenone (ROT, 10µM), and allopurinol (ALLO, 100 µM). Cell toxicity was evaluated by analyzing the exclusion of the trypan blue dye and in every case was over 90 %.
Measurement of intracellular CAT activity and ROS concentration
For determination of catalase enzymatic activity, cells were scraped off in PBS, pelleted by centrifugation for 10 min at 1500 rpm at 4
• C, resuspended in 50 mmol/l potassium phosphate, pH 7
and sonicated for two 15s bursts. Lysates were clarified by centrifugation at 13,000g for 10 min at 4
• C and supernatants were used to determine catalase activity using catalase assay kit. 
Protein extraction and immunoblot analysis
Immediately after treatments, cells were washed with cold PBS and lysed in lysis buffer (50 mM Trizma, pH 8.0, 150 mM NaCl, 0.1% Triton X-100, 10 mM EDTA, 0.25% sodium deoxycholate and protease inhibitors). Cell lysates were sonicated and proteins were resolved onto 8-12 % SDSpolyacrylamide gels. The proteins were transferred to PVDF membrane, blocked with 5% non-fat dry milk in TBS-T (50 mM Trizma, pH 7.6, 150 mM NaCl, 0.1% Tween-20) and incubated overnight at 4
• C with the corresponding primary antibodies and 1h at room temperature with secondary antibodies.
Immunolabeling was detected by enhanced chemiluminescence.
Immunofluorescence analysis
After treatment, cells were fixed with 4% paraformaldehyde in PBS, 10 min at room temperature, rinsed and permeabilized with 0.5% Triton X-100 in PBS (10 min). Cells were then incubated for 1h with 3% BSA in PBS to block nonspecific binding. Afterwards, cells were incubated overnight at 4
• C with anti-TGF-β1 antibody (1:50) and then rinsed with PBS. Finally, cells were incubated with goat anti-Rabbit IgG (1:500) for 1h in the darkness. Slides were washed and mounted with Gold antifade Reagent. Colour detection was performed by confocal microscopy.
Measurement of immunoreactive TGF-β1 by ELISA.
Culture medium (250 µl) from treated cells was removed from each well and incubated with 5
µl 1N HCl for 15 min to activate latent TGF-β1. After, supernatants were neutralized with 1N NaOH.
Samples were analyzed with a commercial TGF-β1 ELISA kit (19) . Protein concentrations were determined spectrophotometrically. Each sample was measured in duplicate and the results were expressed as pg of TGF-β1 per µg of protein.
Analysis of total TGF-ß1 mRNA by quantitative RT-PCR
Total RNA from each sample was extracted and quantified. Two micrograms of total RNA was reverse transcribed to cDNA (High Capacity cDNA Reverse Transcription Kit, Applied Biosystem). 250 ng of cDNA was analyzed for TGF-β1 (Hs00171257_m1) and GAPDH (4326317E)
as endogenous control by using TaqMan gene expression Assays (Applied Biosystem). The normalized gene expression method (2-ΔΔCT ) for relative quantification of gene expression was used.
Transient transfections and assay of luciferase activity
Complete promoter region of the human TGF-β1 gene linked to the luciferase reporter gene and deletion mutants were kindly provided by Dr. Kim (Bethesda, MD). Specifically, luciferaselinked deletion mutants used were: phTG5, which lacks negative regulatory regions located between EDTA, 1 mM EGTA, 1 mM DTT, 10% glycerol, 5 mM NaF and protease inhibitors) for 30 min at room temperature. Samples were run on 8% non-denaturing polyacrylamide gels for 2 h at 200 V. The gels were then dried and exposed to X-OMAT films.
Statistical analysis
Results are expressed as the mean ± SEM. Statistical analysis was performed by either nonparametric Wilcoxon or Friedman tests. A value of *p<0.05 was considered statistically significant.
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